Mouse models have become a central tool for the study of the functional basis of human diseases. The increasing demand of the biomedical researchers for phenotyping, archiving and distribution of mouse models cannot be accommodated with the capacities currently existing in Europe. Infrafrontier Project is funded by the European Commission to set the stage for the implementation of a sustainable research infrastructure for systemic phenotyping, archiving and distribution of mouse models. Infrafrontier Project brings together the leading research facilities from twelve European countries and Canada. The administrative partners of Infrafrontier Project represent national research ministries and funding agencies. Infrafrontier Project is part of the European Strategy Forum on Research Infrastructures (ESFRI) Roadmap since 2006.
The European Mouse Mutant Archive (EMMA) is a non-profit repository for the collection, archiving (via cryopreservation) and distribution of relevant mutant strains essential for basic biomedical research. EMMA's primary objective is to establish and manage a unified repository for maintaining medically relevant mouse mutants and making them available to the scientific community. Therefore, EMMA archives mutant strains and distributes them to requesting researchers. EMMA also hosts courses in cryopreservation, to promote the use and dissemination of frozen embryos and spermatozoa. Dissemination of knowledge is further fostered by a dedicated resource database. The EMMA network is a partnership of institutions from 15 European countries and Israel. EMMA is supported by the partner institutions, by national research programs and by the FP7 Capacities Program of the European Commission.
EurocanPlatform is an EC funded project bringing together 28 European cancer Institutions and organizations to work together in a unique collaboration. The centers are sharing infrastructures and collaborating on projects to help advance cancer research and treatment. The overarching aim of the project is to improve outcomes for cancer patients and reduce mortality. This is being achieved by focusing on three key areas of research: prevention, early detection and improved treatments. EurocanPlatform is building the necessary resources and know-how to improve cancer care from bench to bedside: basic research, early and late translational research, clinical research, epidemiological research, implementation in care and population based outcome research.
Brains On-Line is a contract research organization that operates in the life sciences and pharmaceutical fields, specializing in preclinical in vivo (neuro)pharmacology and pharmacokinetics of drugs in the central nervous system. Brains On-Line provides advanced preclinical in vivo testing using a broad spectrum of research techniques, including microdialysis, bioanalysis, pharmacokinetics, electro-physiology and behavioral studies.